The yeast Saccharomyces cerevisiae genome encodes several proteins that, in laboratory strains, can take up a stable, transmissible prion form. In each case, this requires the Asn/Gln-rich prion-forming domain (PrD) of the protein to be intact. In order to further understand the evolutionary significance of this unusual property, we have examined four different prion genes and their corresponding PrDs, from a number of naturally occurring strains of S. cerevisiae . In 4 of the 16 strains studied we identified a new allele of the SUP35 gene ( SUP35 D D D D 19 ) that contains a 19-amino-acid deletion within the N-terminal PrD, a deletion that eliminates the prion property of Sup35p. In these strains a second prion gene, RNQ1 , was found to be highly polymorphic, with eight different RNQ1 alleles detected in the six diploid strains studied. In contrast, for one other prion gene ( URE2 ) and the sequence of the NEW1 gene encoding a PrD, no significant degree of DNA polymorphism was detected. Analysis of the naturally occurring alleles of RNQ1 and SUP35 indicated that the various polymorphisms identified were associated with DNA tandem repeats ( 
Introduction
The yeast Saccharomyces cerevisiae encodes several functionally distinct proteins that can act as novel epigenetic determinants through a self-propagating change in their conformation. By analogy with the mammalian PrP protein, implicated as the self-propagating infectious agent in a number of neurodegenerative diseases such as Bovine Spongiform Encephalopathy (Prusiner et al ., 1998) , the yeast proteins have been referred to as prions (Wickner, 1994) . Perhaps the best characterized yeast prion protein is Sup35p, the determinant of the [ PSI + ] prion. Sup35p is a component of the yeast translation termination factor (Stansfield et al ., 1995; Zhouravleva et al ., 1995) . In a [ PSI + ] cell, a large proportion of Sup35p appears to be functionally inactive due to aggregation of its prion form (Patino et al ., 1996; Paushkin et al ., 1996) . This leads to a defect in translation termination that can be assayed as enhanced suppression of nonsense mutations in either the ADE1 gene (UGA) or the ADE2 gene (UAA) (Serio and Lindquist, 1999) .
The Sup35p prion protein is modular in both its structure and function. The C-terminal region (aa 254-685) carries out the essential function of the protein in translation termination (Ter-Avanesyan et al ., 1993; , whereas the extreme amino terminus of Sup35p (aa 1-123) defines the prion-forming domain (PrD) that is responsible for the prion-like behaviour of Sup35p but is not essential for Sup35p function per se (Ter-Avanesyan et al ., 1994; Tuite, 2000) . These two regions are separated by the highly charged M (middle) region (aa 124-253) that may contribute to the prion-like properties of this protein (Liu et al ., 2002) . A striking feature of the Sup35p-PrD is the presence of two sequence elements both of which are crucial for the conversion to, and maintenance of, the prion form of Sup35p; a Gln-and Asn-rich region between amino acids 8 and 33 (DePace et al ., 1998) and five complete (and one partial) copies of an oligopeptide (8-9 aa) repeat (Tuite, 2000) . Deletion of one or more of the full repeats (designated R1-R5) prevents the resulting mutant Sup35p from maintaining the [ PSI + ] determinant in the absence of wild-type Sup35p, although the mutant Sup35p molecules are still able to take up the prion state in the presence of wild-type Sup35p (Parham et al ., 2001) . The partial repeat (R6) is dispensable for [ PSI + ] propagation (Parham et al ., 2001) .
Although the amino acid sequence of the Sup35p-Cterminal region is highly conserved from yeast to man (Inagaki and Doolittle, 2000) , the Sup35p-PrD exhibits a high level of divergence in amino acid sequence with significant divergence between relatively closely related yeast species (Inagaki and Doolittle, 2000; Nakayashiki et al ., 2001) . Although several of the fungal Sup35p Nterminal regions have the potential to drive protein aggregation in S. cerevisiae (Chernoff et al ., 2000; Kushnirov et al ., 2000; Santoso et al ., 2000) , only in the case of Kluyveromyces lactis has this property been demonstrated in the natural host species (Nakayashiki et al ., 2001) . A search for the aggregated prion form of Sup35p in several natural isolates and industrial strains of S. cerevisiae revealed that the strains examined were [ psi -] (Chernoff et al ., 2000) . This raises the issue of whether or not [ PSI + ] is a laboratory acquired trait arising as a consequence of long-term growth in a non-native environment.
In addition to Sup35p/[ PSI + ], two other yeast proteins with prion-like properties have been identified in S. cerevisiae : Ure2p/[ URE3 ] (Wickner, 1994) and Rnq1p/[ RNQ + ] ( Sondheimer and Lindquist, 2000) . Each contains regions with the characteristic features of the Sup35p-PrD, namely a high Gln and/or Asn content and few charged residues. A third protein, New1p, also has a PrD (Santoso et al ., 2000) although it remains to be established whether the New1p protein per se is a prion. Neither the function of Rnq1p or New1p has been identified apart from their prion-like properties nor has a phenotype been associated with the presence of the respective prion form. [
-is commonly found in many laboratory strains (Sondheimer and Lindquist, 2000) .
To gain a fuller understanding of the evolutionary importance of yeast prions and their prion-forming domains requires a detailed analysis of the structure and behaviour of these proteins in non-laboratory strains of S. cerevisiae . Jensen et al . (2001) have recently reported the results of a sequence survey of the Sup35p PrDM region (aa1-253) from 23 strains of S. cerevisiae , over half of which were clinical isolates. Intriguingly, they only identified three alleles with single non-synonymous amino acid substitutions in the Sup35p-PrD and only one of these (a Q30R substitution) was within the region we have defined as required for PrD activity (Parham et al ., 2001) . The aim of our study was to extend this approach to other prion genes and in so doing have discovered novel polymorphisms in both the SUP35 and RNQ1 genes that can be attributed to deletion or expansion of short ( < 50 bp) tandem nucleotide repeats within the coding sequences of these genes.
Results

Identification of a novel SUP35 allele in clinical isolates of S. cerevisiae
In order to explore the frequency with which both nonsynonymous and synonymous nucleotide substitutions occur within the PrDM-encoding region of the SUP35 gene, this region was amplified by high fidelity PCR from 16 different clinical isolates of S. cerevisiae (SCI1-16; Table 1 ) and both strands sequenced. The Sup35p-PrD from four strains (SCI3, SCI4, SCI7 and SCI11) were found to have an identical 19 aa deletion when compared with the Sup35p-PrD sequence from the other 12 strains examined and to the two originally reported SUP35 gene sequences from laboratory strains (Accession no. M21129, Kushnirov et al ., 1988; X07163, Wilson and Culbertson, 1988) . We designate this allele SUP35 D 19. The deletion, spanning amino acids 59-77, removed one complete oligopeptide repeat (R3) and parts of the two flanking repeats R2 and R4 ( Fig. 1) with the resulting PrD only carrying three intact oligopeptide repeats. A number (Parham et al ., 2001) . A total of six different SUP35 alleles were detected amongst the 16 strains studied (Fig. 1) .
The complete nucleotide sequence of the SUP35 gene was determined for four of the strains (SCI2, 3, 4 and 6) with several nucleotide differences being identified in the C domain, although only one of these (in strain SCI3) resulted in an amino acid difference (Q658H). All of the strains -with the exception of SCI9 -could be induced to sporulate although we obtained no evidence for heterozygosity at the SUP35 locus in any of these strains. (Cox, 1965) , the haploid segregants from such a cross would be expected to give rise to 2 red:2 white (2R:2W) spore clones for each tetrad if the strains were [psi - ]. In contrast, if they were [PSI + ], one would expect a range of spore phenotypes with indi- Fig. 1 . Amino acid sequence alignment of Sup35p (amino acid 1-214) encoded by five different naturally occurring SUP35 alleles of Saccharomyces cerevisiae. The upper sequence (ScSup35) is that originally reported by Kushnirov et al. (1988) and Wilson and Culbertson (1988) . Amino acid differences are underlined and their position indicated by the downward arrow (positions 34, 109, 162 and 206) . The five complete (R1-R5) and the one partial oligopeptide repeat (R6) are boxed. The deletion found in the SCI3 and SCI4 strains is indicated by the hatched box. The Met residue that defines the start of the M domain (at residue 124) is indicated.
vidual asci showing either 2R:2W, 1R:3W or 0R:4W. In total, 26 tetrads were analysed from such crosses involving two independent SCI3 spores (2c and 5b) and 16 tetrads involving two independent SCI4 spores (3b and 7b). The spore segregation results obtained for both strains clearly indicated that the haploid spores were [psi - ] with a 2R:2W segregation pattern. Poor spore viabilities (<20%) among the other three strains (SCI2, SCI5 and SCI6) meant that statistically significant segregation data could not be obtained.
Oligopeptide repeat deletions in the Sup35p-PrD give rise to a dominant antisuppressor phenotype because the mutant Sup35p is unable to interact with the wild-type Sup35p to form prion aggregates and is therefore available to interact with eRF1 (Sup45p) to form an active eRF complex (Ter-Avanesyan et al., 1994; DePace et al., 1998; Parham et al., 2001) . However, such strains retain 'cryptic' [PSI + ] seeds composed of the wild-type Sup35p (Parham et al., 2001) . To evaluate whether Sup35p encoded by the SUP35D19 allele behaved similarly, we exploited a plasmid-based assay that allowed us to test the consequences of Sup35p-PrD manipulations on [PSI + ] maintenance and transmission (Parham et al., 2001) .
The PrD-encoding region (aa 1-114) of SUP35D19 was amplified by PCR from the SCI3 and SCI4 strains and inserted in frame with the wild-type MC domain-encoding region of SUP35 to generate the plasmids pUKC1512-SCI3 and pUKC1512-SCI4 respectively. These two plasmids were individually transformed into the [PSI + ] strain MT700/9d which carries both a disruption of the chromosomal SUP35 locus (sup35::kanMX) and the URA3-based plasmid pYK810 carrying a copy of the wild-type SUP35 gene (Parham et al., 2001 , after loss of the plasmid after extensive growth of the transformants on non-selective medium. These data show that the natural truncated Sup35p variant encoded by the SUP35D19 allele is not 'curing' [PSI + ] from the strain, but rather is an ASU ('antisuppressor') allele as defined by DePace et al. (1998) .
Polymorphisms in three other yeast prion genes: URE2, RNQ1 and NEW1
The finding of naturally occurring polymorphisms in the SUP35 gene that inactivated its prion-like behaviour lead Fig. 2 . Western blot analysis of the soluble fraction prepared from cell-free lysates of clinical isolates of S. cerevisiae (SCI3 and 4). Cellfree extracts were prepared from two clinical strains, SCI3 and SCI4 and fractionated, as described in Experimental procedures, into total (T), soluble (S) and pellet (P) fractions. Following SDS-PAGE using 10% acrylamide gels, protein samples were transferred to nitrocellulose and the Sup35p protein detected using an anti-S. ] derivative of MT700/9d as described in the text. After 5FOA selection, individual transformants were spotted onto either rich medium (1/4 YEPD), rich medium containing 3 mM guanidine hydrochloride (GdnHCl) or onto defined medium lacking adenine (-Ade). The results shown are after incubation at 30∞C for 4 days.
us to determine whether the other three genes of S. cerevisiae, known to encode prion proteins, were polymorphic. Using high fidelity PCR we amplified and sequenced the PrD-encoding sequences from the RNQ1 (Sondheimer and Lindquist, 2000), NEW1 (Santoso et al., 2000) and URE2 (Wickner, 1994) genes from six of the clinical isolates of S. cerevisiae, including two of the strains homozygous for the SUP35D19 allele.
Neither non-synonymous nor synonymous substitutions were found in the PrD-encoding region of URE2 (amino acids 1-65, Masison and Wickner, 1995) when the deduced sequences were compared with the previously reported URE2 gene sequence (URE2/YNL229C Accession no. M35268). Alignment of the six deduced New1p-PrD encoding sequences (amino acids 1-153; Santoso et al., 2000) , from the same six strains, with the previously reported NEW1 gene sequence (NEW1/YPL226W, Accession no. NC001148) revealed several nucleotide sequence differences between the different NEW1 sequences within this region. Only one of these was a non-synonymous substitution; in the strain SCI16 an A to G change at nucleotide 208 of the open reading frame (ORF) results in Asp70 instead of Asn70. No heterozygosity, at either the URE2 or NEW1 loci, was observed in these strains.
Comparison of the C-terminally located Rnq1p-PrDencoding region (amino acid 153-405; Sondheimer and Lindquist, 2000) from the same six wild-type strains, with the published RNQ1 sequence (RNQ1/YCL028W Accession no. NC001135) indicated a much greater number of polymorphisms at this locus within the PrD-encoding region. Initially, sequence data were generated for the PCR-amplified RNQ1-PrD region from the six original diploid strains. Three of the strains (SCI3,4 and 10) gave unambiguous DNA sequencing results whereas DNA sequence analysis of PCR products from three other strains (SCI7, SCI9 and SCI11) gave ambiguous sequences indicating heterozygosity at the RNQ1 locus in these three strains. For two of these latter strains (SCI7 and SCI11) we were able to generate several haploid spores whereas SCI9 was asporogenous. We independently cloned the different RNQ1 alleles from SCI7 and SCI11 spores after high fidelity PCR amplification from the original diploid strain.
Eight different RNQ1 alleles (designated A-H) were identified among the six diploid strains studied (Fig. 4) . We consistently found two silent nucleotide substitutions compared with the published RNQ1 sequence (RNQ1/ YCL028W Accesion no. NC001135); a T instead of C at position 930, and C instead of T at position 1098. Four of the six strains had RNQ1 alleles with His360 (CAC) rather than the published Gln360 (CAG). The RNQ1 allele in SCI4 (allele D) had an additional amino acid substitution: A. Schematic representation of the RNQ1 coding sequence indicating the location of the prion-forming domain (PrD; aa153-405) as defined by Sondheimer and Lindquist (2000) , and the location of the various polymorphic regions (A, B, C) and the positions of the single amino acid polymorphisms (*). B. Amino acid sequence polymorphisms detected in the eight different RNQ1 alleles (A-H). The amino acid positions are indicated in brackets. Allele A is the sequence originally deposited in the GenBank database under Accession no. NC001135 A -indicates a missing residue compared with the GenBank sequence. C. A summary of the RNQ1 and SUP35 alleles present in the six different strains. Note that strain SCI11 has three alleles most probably because the strain is trisomic for chromosome III which carries the RNQ1 gene.
Leu387 (TTA) rather than the published Phe387 (TTC) sequence. The asporogenous strain SCI9 was heteroallelic at the RNQ1 locus with one allele (allele F) containing a 33 bp deletion leading to a deletion of 11 amino acid between residues 297-307 (Fig. 4) . Sequence analysis of the RNQ1 alleles in the other two heteroallelic strains SCI7 and SCI11 identified a variety of additional polymorphisms including 6, 12 and 33 bp in frame deletions and a 42 bp in frame insertion relative to the published RNQ1 sequence (Fig. 4) . The various deletions/insertions mapped to one of three distinct regions (designated A, B and C on Fig. 4 ) with regions B and C being within the Rnq1p-PrD as defined by Sondheimer and Lindquist (2000) . Intriguingly, the strain SCI11 appeared to contain three different RNQ1 alleles (alleles B, C and H; Fig. 4 ) indicating that this strain was either triploid or trisomic for chromosome III. These polymorphisms clearly generated Rnq1p protein molecules of different lengths and with different Asn + Gln content in the Rnq1p-PrD, changes which could impair the formation of the [RNQ + ] prion in these strains.
Maintenance of the [RNQ
With such a degree of polymorphism within the Rnq1p-PrD it was important to determine the [RNQ] status of the haploid strains carrying the various RNQ1 alleles derived from strains SCI7 and SCI11. To do this we relied on Rnq1p sedimentation analysis (Sondheimer and Lindquist, 2000) . All of the haploid strains derived from SCI7 or 11 were [rnq - ] with the majority of the Rnq1p being in the soluble fraction (Fig. 5) Fig. 2; data not shown).
The PrD-encoding regions of yeast prion protein-encoding genes contain tandemly repeated nucleotide sequences
The detection of a common length polymorphism within the oligopeptide repeat-containing region on the S. cerevisiae SUP35D19 allele lead us to ask whether the deletion was related to deletion of an underlying DNA repeat within this region. An analysis of the Sup35p-PrD coding sequence, using the 'Tandem Repeats Finder' program (Benson, 1999) , identified a tandemly repeated 57 bp sequence containing 10/57 nucleotide mismatches (Fig. 6) . The 19-amino-acid deletion in the truncated Sup35p encoded by the SUP35D19 allele corresponded with the first of these repeats (Fig. 6) . Therefore, there is a previously undescribed 57 bp (19 amino acid) duplication in the SUP35 gene within the PrD-encoding region. No such nucleotide repeats were evident in the M or C regions.
A similar analysis of the PrD-encoding regions of the URE2, RNQ1 and NEW1 genes revealed the existence of a number of other repeated DNA sequences ranging in size from 6 to 42 nucleotides, excluding trinucleotide repeats (Table 2) . Significantly, the various polymorphisms identified in the RNQ1 gene were all associated with repeated nucleotide sequences ( Table 2 ). The URE2 gene, which showed no polymorphism in the strains we examined, had no nucleotide repeats other than 18 tandemly repeated Asn codons (AAT/C).
Discussion
Evolutionary significance of SUP35 gene polymorphisms
Comparisons between homologues from a range of eukaryotic species has revealed that the N-terminal Sup35p-PrD is highly variable both in amino acid compo- sition and length (Inagaki and Doolittle, 2000; Nakayashiki et al., 2001) whereas the essential C-terminal domain shows a much higher degree of cross-species amino acid sequence identity. Only one reported Sup35p sequence lacks such a variable N domain, namely that of the Giardia lamblia, an 'early diverging eukaryote' (Inagaki and Doolittle, 2000) . We report here the discovery of a novel, naturally occurring SUP35 allele SUP35D19 that encodes a Sup35p protein lacking 19 amino acids within the oligopeptide repeat-carrying region of the PrD. The resulting Sup35p contains only three rather than the usual five copies of the oligopeptide repeat in the Sup35p-PrD. These repeats, which are related in sequence to the 'octarepeats' present in the mammalian prion protein PrP (Tuite, 1994) a. The nucleotide position of the repeated sequences given relative to the A of the ATG (initiation codon) of the coding sequence as +1.
described occur in strains isolated from different niches as to date only one non-laboratory strain has been studied and this had no polymorphisms in the Sup35p-PrD (Jensen et al., 2001) . While the function of the N-terminal Sup35p PrD is relatively well established, the role of the non-essential M domain is far from clear. It is a highly charged region of the protein molecule that may act as a flexible linker between the N and C domains (Serio and Lindquist, 1999) . We have identified two non-synonymous substitutions in the M domains (Fig. 1) , but it remains to be established if these mutations influence the prion-like behaviour of the Sup35p. Gross changes to the M domain of Sup35p can certainly influence the propagation of the [PSI + ] prion determinant although derivatives of Sup35p lacking the M domain can exist in the prion form (Liu et al., 2002) .
Within the four SUP35 C-terminal domains sequenced, only one non-synonymous substitution was found; a Q658H substitution in the SCI3 strain. Jensen et al. (2001) only found one non-synonymous nucleotide polymorphism in the C domain among the 23 strains they studied. These data suggest that the essential functional C domain of Sup35p is under different selective pressures to the non-essential (for viability) PrD and M domains.
The RNQ1 prion gene is highly polymorphic
Our analysis of the RNQ1 gene from six different clinical isolates of S. cerevisiae identified eight different RNQ1 alleles (Fig. 4) . Three of the strains were heteroallelic for this locus on chromosome III with one strain (SCI11) apparently trisomic for chromosome III. The product of this gene, the Rnq1p protein, gives rise to the transmissible [RNQ + ] determinant that is present in most laboratory strains of S. cerevisiae (Sondheimmer and Lindquist, 2000) . To date, however, no biochemical function has been assigned to the Rnq1p protein although cells that are [RNQ + ] show a higher rate of de novo appearance of several other yeast prion determinants (Derkatch et al., 2001; Osherovich and Weissman, 2001) .
In haploid strains derived from two of the clinical strains examined, i.e. SCI7 and SCI11, Rnq1p was mostly present in the soluble fraction indicating these strains were [rnq -] (Fig. 5) . It was noticeable that the four different RNQ1 alleles in these strains contained deletions of either GQ (alleles C, G) or GQGQ (alleles B, H) between residues 162-165 when compared with the originally reported RNQ1 allele (Fig. 4) . Furthermore, RNQ1 alleles G and H contained both an 11-amino-acid deletion between residues 286-296, and an insertion of 14 amino acids between residues 372 and 373. In all cases these variations occur within the Rnq1p-PrD as defined by Sondheimer and Lindquist (2000) . The two clinical strains which contained RNQ1 alleles without such changes, i.e. SCI3
(allele E/E) and SCI4 (allele D), were both [RNQ + ] (Fig. 5) , although intriguingly both were homozygous for the SUP35D19 allele.
That both the [RNQ + ] and [PSI + ] prion determinants can be stably maintained in the same cell (Derkatch et al., 2001; Osherovich and Weissman, 2001) shows that having two different prion determinants in the same host cell is not necessarily detrimental to the cell. This is exemplified by the study of Derkatch et al. (2001) 
Role of tandem repeats in evolution of prion genes/proteins
The two prion genes which showed the most significant degree of polymorphism among the natural isolates we studied (i.e. SUP35 and RNQ1) both contain tandemly repeated nucleotide sequences in their PrD-encoding regions (Table 2 and Fig. 6) . Significantly, the polymorphisms we identified in these two genes were generated by changes in numbers of copies of these tandemly repeated sequences. For example, the SUP35D19 allele presumably arose as a consequence of unequal crossing over between the two 57 bp (19aa) repeats (Fig. 6 ) although we did not find a SUP35 allele with the reciprocal of such an event, i.e. carrying three copies of the 57 bp repeat. Such alleles, were they to be found, would be of considerable interest as Liu and Lindquist (1999) have provided evidence that increasing the numbers of oligopeptide repeats within the Sup35p PrD leads to a 1000-fold increase in the de novo appearance of [PSI + ]. The failure to find such an allele could again be taken as evidence for a selective pressure against an ability to efficiently switch to the [PSI + ] state in clinical strains of S. cerevisiae although greater numbers of strains need to be analysed before a firm conclusion can be reached. A search for DNA repeats in other available fungal SUP35 gene homologues revealed a variety of tandemly repeated DNA repeats within the putative N-terminal PrD regions of these proteins, all of which were multiples of three nucleotides (C. G. Resende and M. F. Tuite, unpubl. data) . We have also recently reported the existence of naturally occurring length polymorphisms within the N domain of the Candida albicans Sup35p homologue (CaSup35p; Resende et al., 2002) although in this case the polymorphisms appear to result from expansion (or contraction) of a much smaller trinucleotide repeat (CAA) leading to changes in the number of tandem polyglutamine residues. However, this trinucleotide (or the related CAG) may be particularly susceptible to deletion or amplification; for example expansion of polyglutamine tracts within the human Huntingtin gene is associated with an increased propensity to protein aggregation and concomitant neurodegeneration (Usdin and Grabczyk, 2000) . In contrast, we did not uncover any S. cerevisiae URE2 alleles, in our limited analysis, with changes in the number of Asn residues in the Ure2p-PrD, although the longest poly Asn tract in the Ure2p protein is only 7 of which 5 are encoded by the AAT codon.
There are numerous examples of short tandem DNA repeats in eukaryotic genomes. Such repeats display high rates of polymerase slippage during replication (Strand et al., 1993) or DNA recombination events between multiple loci consisting of homologous repeat motifs (Jankowski et al., 2000) resulting in either expansions or contractions of the repeat number. Tandem DNA repeat instabilities have also been reported in S. cerevisiae; for example, Freudenreich et al. (1997; and Maurer et al. (1996) have shown that CAG repeat contraction can occur during mitosis while both contraction and expansion can occur during meiosis (Schweitzer et al., 2001) . Larger DNA repeats (e.g. 36 bp) also show expansions and contractions in meiosis (Paques et al., 2001) . Studies in yeast have shown that trinucleotide repeats are clustered in regulatory genes and primarily located in non-essential regions of the proteins indicating a possible novel form of gene regulation with important consequences for evolution by acting as a source of genetic variation (Young et al., 2000) .
Internal protein repeats are found in about 17% of all yeast proteins whereas the frequency is much lower in prokaryotes. This has lead Marcotte et al. (1998) to propose that proteins containing such repeats may evolve at a faster rate than those that do not. This would mean that proteins with internal repeats would facilitate faster adaptation to changing environments. In bacteria, there are several well-documented examples of genes in which tandem DNA repeat expansion or contraction within coding sequences result in alteration in the nature and hence function of the gene product, e.g. the Opa genes of Neisseria gonorrhoeae and the LPS genes of Haemophilus influenzae (Moxon et al., 1994) . Why might there be a need for rapid evolution of the sequence of the Rnq1p protein? The central importance of the prion form of Rnq1p in the de novo conversion of other yeast prions (Derkatch et al., 2001; Osherovich and Weissman, 2001) might provide the clue. The potential for rapid evolutionary changes to the Rnq1p-PrD would in turn alter the frequency at which other prions could potentially raise de novo in the population. As suggested by True and Lindquist (2000) the ready emergence of prions such as [PSI + ] may play an important role in the 'evolvability' of yeast by facilitating adaptation to changes in the cell's environment without necessarily that change in environment triggering the prion conversion. A detailed analysis of the prion-like properties of the Rnq1p variants we have described here, together with a study of the mitotic and meiotic stability of the identified tandem DNA repeats, will be required to support this hypothesis.
A link between prion gene polymorphism and de novo prion conversion may not be restricted to yeast prions. The mammalian prion protein gene (Prnp) contains a 24 bp repeat region coding the octapeptide repeat, a sequence that bears some resemblance to the oligopeptide repeat in Sup35p (Parham et al., 2001) . A number of polymorphisms have been identified in Prnp that involve this repeated sequence (Palmer and Collinge, 1993) . The deletion of PrP octarepeat repeats, while not eliminating disease in experimental models, does lead to a reduction in the severity of the associated neuropathology consistent with a reduced rate of conversion (Flechsig et al., 2000) . However, Prnp alleles with an expansion in the number of these repeats is associated with some inherited forms of prion diseases, including Kuru, CreutzfeldtJakob disease (CJD), and Gerstmann-Straüssler Scheinker syndrome (GSS) (Palmer and Collinge, 1993; Vital et al., 1999) , i.e. these individuals show a higher rate of de novo conversion of PrP C to the disease-associated PrP Sc form.
Experimental procedures
Saccharomyces cerevisiae strains SUQ5 ade2-1 UAA his3-11,-15 ura3-1 leu2-3,-112; Doel et al., 1994) his3-11,-15 ura3-1 leu2-3,-112) -200 leu2-3,-112 trp1-289 ura3-52; Chernoff et al., 1995) was used in the genetic studies for evaluating the capacity of S. cerevisiae clinical isolates to maintain [PSI + ]. Strain MT700/9d (MATa, sup35::kanMX4, SUQ5, transformed with pYK810 (a centromeric plasmid-containing SUP35; Kikuchi et al., 1988) was used in prion propagation assays (Parham et al., 2001) .
Six clinical isolates of S. cerevisiae were obtained from Professor Frank C. Odds (Janssen Research Foundation; Table 1 ). All six strains gave an assimilation pattern on an API ID32C test confirming, with better than 98% probability, that these were strains of S. cerevisiae. Ten different isolates of S. cerevisiae from a variety of clinical sources (Table 1) were provided by Dr Patrick Dorr (Pfizer Global Research) and were originally obtained from the UK National Collection of Pathogenic Fungi (NCPF).
Genetic techniques
Standard yeast media, cultivation procedures and genetic techniques were used (Kaiser et al., 1994) . Tetrad dissection was performed on a Singer MSM System Micromanipulator. The clinical isolates of S. cerevisiae were sporulated on a standard nitrogen-depleted medium (SMA; 0.25% yeast extract, 1% potassium acetate, 0.05% glucose, 0.2% adenine) and the resulting tetrads dissected on to YEPD. [rho -] strains were generated by growth in the presence of ethidium bromide (10 mg ml -1 ) on solid YEPD medium and identified by their inability to grow on a non-fermentable carbon source (YEPG; 1% yeast extract, 2% bactopeptone, 2% glycerol).
The (Derkatch et al., 1996) 
Recombinant DNA techniques
Standard protocols were used for DNA isolation, electrophoresis, DNA fragment purification, restriction enzyme digestion and PCR (Sambrook et al., 1989) . Restriction enzymes and DNA polymerase (Expand TM. ) were purchased from Boehringer Mannheim, 'High Fidelity' Pwo polymerase from Roche. Oligonucleotides were purchased from MWG Biotech UK Ltd.
Sedimentation analysis of Sup35p and Rnq1p
Total protein extracts were prepared from various S. cerevisiae strains and fractionated into soluble and insoluble (pellet) fractions by centrifugation essentially as described by Eaglestone et al. (1999) for Sup35p and as described by Sondheimer and Lindquist (2000) for Rnq1p. The resulting protein samples were analysed on 10% SDS-polyacrylamide gels and electrophoretically transferred to nitrocellulose (Sartorius) for Western blot analysis, employing an affinitypurified polyclonal antibody raised against recombinant S. cerevisiae Sup35p or Rnq1p, respectively, essentially as described by Stansfield et al. (1995) . Anti-rabbit secondary antibody and the ECL reagent (Pharmacia-Amersham) were used to detect bound antibody according to the manufacturer's protocols. Molecular weights of proteins were estimated using pre-stained molecular weight standard markers (Sigma).
PCR amplification and sequencing of various prion-forming domains
The PrD M-encoding region of the SUP35 gene of S. cerevisiae was amplified from the S. cerevisiae clinical isolates using the 'High Fidelity' Pwo polymerase (Roche) which contains a 3¢-5¢ proofreading activity, together with the oligonucleotide primers: SUP35-FOR and P3 with extensions bearing BamHI and XhoI restriction sites respectively (Table 3 ). The resulting PCR products were directly sequenced, by the chain termination method (Sanger et al., 1977) , on both strands for each of the 16 SUP35 PrD M domains with exception of strains SCI1 and SCI5 for which only the PrD-encoding region was sequenced. The sequence data have been deposited with GenBank (Accession no. AY028644 -AY028659; Table 1 ). Sequencing of the fulllength SUP35 gene from S. cerevisiae strains SCI2, SCI3, SCI4 and SCI6 was done after PCR amplification with the primers SUP35-FOR and REV-Xba (Table 3) with the resulting PCR products being sequenced on both strands. Three additional primer pairs were designed (SUP35-1F/1R, SUP35-2F/2R and SUP35-3F/3R; Table 3 ) to create DNA fragments with overlapping regions to facilitate the sequencing of the full-length SUP35 gene. The PrD-encoding regions of the URE2 (aa 1-97) and NEW1 (aa 1-153) genes were PCR amplified by PCR using primer pairs URE2-F/URE2-R and NEW1-F/NEW1-R respectively (Table 3) . The larger C-terminal PrD-encoding region of the RNQ1 gene (aa 141-405) was amplified by PCR using primer pairs RNQ1-F/RNQ1-MR and RNQ1-MF/ RNQ1-R (Table 3) . Resulting PCR products were sequenced, by the chain termination method, on both strands. The sequence data have been deposited with the GenBank database as follows: RNQ1 alleles (Accession Nos. AY028674-AY028685), URE2 alleles (Accession nos. AY028692-AY028697) and NEW1 alleles (Accession Nos. AY028686-AY028691).
Because preliminary sequence data for RNQ1 indicated heterozygosity at this locus in the strains SCI7, SCI9 and SCI11, two of these strains, SCI7 and SCI11 were sporulated and haploid progeny (SCI7.2/a, SCI7.2/b, SCI7.2/d and SCI11.5/a, SCI11.5/b, SCI11.5/c, SCI11.5/d respectively) was generated. SCI9 was asporogenous and so the two different RNQ1 alleles were cloned from the diploid strain into pGEM-T Easy (Promega) after PCR amplification and sequenced as described above.
DNA and protein sequence analysis
To identify tandemly repeated DNA sequences in the various sequenced SUP35, URE2, NEW1 and RNQ1 genes of S. cerevisiae, the 'Tandem repeats finder' programme (Benson, 1999) was used. Alignment of the nucleotide and protein sequences was carried out using CLUSTALW (Thompson et al., 1994) .
Plasmid construction
The construction of the plasmid pUKC1512, carrying the SUP35 promoter (-919 to -49 with respect to the translation start codon) and the MC-domains of the SUP35 gene, has been previously described (Resende et al., 2002) . Plasmid pUKC1512-SCI3 and pUKC1512-SCI4 were constructed as follows: the PrD-encoding regions of the SUP35 gene from the S. cerevisiae strains SCI3 and SCI4, respectively, were PCR amplified from genomic DNA as a BamHI/EcoRV fragment, using primers SUP35-FOR and REV-7 (Table 3 ). The resulting DNA fragment was then inserted into plasmid pUKC1512 in frame with MC domains of the ScSUP35 gene.
Plasmid shuffling assay
Wild-type and recombinant SUP35 genes were transformed into the [PSI + ] and [psi -] derivatives of the S. cerevisiae haploid strain MT700/9d (Resende et al., 2002) that carries the sup35::kanMX4 allele, and the centromeric plasmid pYK810 (Kikuchi et al., 1988) which carries the SUP35 and URA3 genes. These strains were transformed with the various plasmids each carrying the HIS3 gene and the different SUP35 constructs. His + transformants were selected in SDHis medium, and single transformants were then streaked onto both SD-His medium and YEPD medium containing 5-fluoroorotic acid (5-FOA, 1 mg ml -1 ), to select for Ura -strains that have lost the URA3-containing plasmid (Kaiser et al., 1994) . From SD-His and 5-FOA plates, individual colonies were isolated and replica plated onto 1/4YEPD, SD-His, SDUra, SD-Ade, YEPD + 200 mg ml -1 Geneticin (G418) and YEPD + 3 mM GdnHCl to verify their genotypes and associated phenotypes.
